Clinical Trial Laboratory Testing

Global laboratory support for all phases of clinical trial testing.

Contact Us


The best science is inspired by patients, so we are redefining the role of a central lab.  

We've connected our entire organization to clinical trial testing expertise—staying at the forefront of science and helping you navigate drug development's biggest challenges. 

We use cutting-edge technology platforms and assays, powered by scientific knowledge, to seamlessly deliver fully integrated specialty testing across our global network of labs. 

With five global central laboratories, we're working around the clock to monitor sample transportation and provide investigator support. 

Clinical testing in a lab


Featured Video

Propel your biomarker strategy

PhD-level leaders within our Biomarker Solution Center can provide specialized therapeutic area expertise to create a successful biomarker strategy for your next study.


By the Numbers


unique clinical investigator sites globally (Central Laboratory Services)

98% +

kits received within stability (2022)


global biotech and pharmaceutical partners supported each year (ED + CLS, inclusive of BioA and CMC)


protocols (Central Laboratory Services, 2018-2022)


Featured Resources


The modulatory effects of a PI3Kδ specific small molecule inhibitor (IOA-244) on basophil degranulation measured by flow cytometry

During this short 8-minute presentation, our staff scientist Eirini Kamileri, PhD evaluates the performance of the IOA-244 drug (a selective PI3Kδ inhibitor), on IgE-induced basophilic activation, through flow cytometry.


Supporting CAR T cell development with a translational biomarker strategy

Biomarkers play a critical part in accelerating CAR T-cell development. This 25-minute session, delves into the importance of a translational biomarker strategy in assessing safety and efficacy to navigate regulatory pathways in rapid development of CAR T-cell therapies.


De-Risk and streamline your drug substance & drug product testing

The development of a new biologic requires effective management of time and risk. The drug manufacturing process will progress in scale and likely location for both drug substance and drug product.


Challenges & best practices in supporting clinical bioanalysis in China

In this on-demand webinar, learn more about the key considerations and best practices for supporting your global clinical trial with regulated bioanalysis in China. Topics covered include: special requirements for China submission studies, differences in global quality standards and technical expertise, resourcing and customs challenges in China, and advanced technologies for supporting existing and emerging modalities.


Speak with a specialist

Let us know about your interests and one of our specialists will contact you directly.

Contact Us